Understanding NSCLC Treatment When You Have an EGFR Mutation

Learn more about lung cancer at www.YouAndLungCancer.com
This animation provides an overview of EGFR mutations in non-small cell lung cancer (NSCLC) and different treatment options. The good news is that specific treatments can target EGFR mutations. If you have an EGFR mutation, you may be a candidate for targeted therapy, and there are many treatments that target EGFR. Watch to learn about tyrosine kinase inhibitors (TKIs), monoclonal antibody drugs, managing side effects, the importance of repeat biomarker testing, clinical trials, and more.

[@YoungLungCancer]

Thank you. Many members of our young lung cancer community have EGFR NSCLC.